Home | Contact Us | Log In
(888) 789-6604
Report Stack
 
Filter your search by:
Region
Publisher
Publish date
Search By Price Range
From:$
    To:$
 
To receive alerts for latest Pharma & Healthcare reports, signup here.
Email ID
 
Pharma & Healthcare | Clinical Diagnostics | Cancer Diagnostics
Reports For Pharma & Healthcare | Clinical Diagnostics Sort By :
Title Date Price
Cancer Diagnostic Technologies: Assessment of Emerging Technologies and Market Applications
By Venture Planning Group
This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their ...Read More
Oct 2010 $1850.00
Cancer Diagnostic Testing Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
By Venture Planning Group
This report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for tumor marker testing.Contains 25 pages
Oct 2010 $950.00
Emerging Cancer Diagnostic Tests and Companies Developing New Technologies and Products
By Venture Planning Group
The report provides a comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such ...Read More
Oct 2010 $2850.00
Leading Cancer Diagnostics Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants
By Venture Planning Group
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technolo ...Read More
Oct 2010 $2500.00
The 2011 Cancer Diagnostics Market: New Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks
By Venture Planning Group
The report identifies major opportunities emerging in the cancer diagnostics market during the next ten years; proposes “ideal” product models with tentative prices and operating characteristics; and suggests alternative business expansion strategies for suppliers.Contains 15 pages
Oct 2010 $850.00
The 2011 Cancer Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers
By Venture Planning Group
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...Read More
Oct 2010 $28500.00
The 2011 French Cancer Diagnostics Market
By Venture Planning Group
This report presents a comprehensive analysis of the French cancer diagnostics market, including:Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demogra ...Read More
Oct 2010 $5400.00
The 2011 German Cancer Diagnostics Market
By Venture Planning Group
This report presents a comprehensive analysis of the German cancer diagnostics market, including:Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demogra ...Read More
Oct 2010 $5400.00
The 2011 Global Cancer Diagnostic Market Overview - Facilities, Test Volumes, and Sales Forecasts by Country
By Venture Planning Group
This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of lab ...Read More
Oct 2010 $950.00
The 2011 Italian Cancer Diagnostics Market
By Venture Planning Group
This report presents a comprehensive analysis of the Italian cancer diagnostics market, including:Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demog ...Read More
Oct 2010 $5400.00

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z